PV Bulletin

TGA to consult on additional controls for an active sunscreen ingredient

The TGA is proposing additional safeguards for 4-methylbenzylidene camphor (4-MBC), impacting regulatory practices for manufacturers.

Primary source: Safety monitoring and information

PV Impact Brief

MonitoringConfidence: high

What changed

The TGA is reviewing regulatory controls related to 4-MBC, indicating potential changes in guidance that may necessitate additional safety evaluations and controls for products containing this ingredient.

Why it matters

These proposed changes will affect how manufacturers respond to safety concerns related to 4-MBC, ensuring better consumer safety and compliance with evolving regulatory standards.

Action needed

PV teams should prepare for potential updates in SOPs to include new safety evaluation procedures concerning 4-MBC and implement monitoring for consultation outcomes to align compliance and regulatory responses.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 11, 2026

Full briefing

Practical implication

PV teams should prepare for potential updates in SOPs to include new safety evaluation procedures concerning 4-MBC and implement monitoring for consultation outcomes to align compliance and regulatory responses.

The TGA has announced a consultation process regarding proposed additional controls for 4-methylbenzylidene camphor (4-MBC), an active ingredient in some Australian sunscreens, which may result in changes to safety reporting and product formulation requirements for manufacturers.

What changed: The TGA is reviewing regulatory controls related to 4-MBC, indicating potential changes in guidance that may necessitate additional safety evaluations and controls for products containing this ingredient.

Why it matters: These proposed changes will affect how manufacturers respond to safety concerns related to 4-MBC, ensuring better consumer safety and compliance with evolving regulatory standards.

Practical implication: PV teams should prepare for potential updates in SOPs to include new safety evaluation procedures concerning 4-MBC and implement monitoring for consultation outcomes to align compliance and regulatory responses.

View original source

  • Source: TGA Safety Alerts - Media releases feed
  • Published at source: 2026-09-11T00:00:00.000Z
  • Discovered by monitor: 2026-09-11T21:15:25.420Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signals#Australia#Guidance#Source-ingestion#Regulator-monitor#Tga.gov.au

Related updates for your role

publicEuropean Medicines Agency · European Union · Updated Sep 10, 2026Translated From French

Veterinary medicinal products containing amoxicillin - referral

Urgency: High

Marketing authorization holders must prepare to submit any relevant pre-clinical and clinical data pertaining to amoxicillin's dosing regimens in pigs during the review.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM · France · Updated Sep 10, 2026Translated From French

Philips MRI Systems with DTI Safety Notification

Urgency: High

Affected healthcare facilities must archive the safety notification and submit responses to Philips regarding necessary safety measures within 30 days.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 10, 2026Translated From Another Language

Haux-Starmed 2500/5,5/SC3 Hyperbaric Chamber Safety Update

Urgency: High

Healthcare facilities using the Haux-Starmed 2500/5,5/SC3 must initiate system modernization immediately and ensure that staff are trained in manual operation procedures, with a signed acknowledgment letter to be returned to Haux Life Support as soon as possible.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Safety Signals
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 10, 2026

Introduction of Overnight Visitor Levy by Local Leaders in England

Monitoring

Local authorities must conduct public consultations on the levy and submit spending plans by early 2028 as a condition for implementation.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward